Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value (VIST) Price & Performance

Ginkgo Bioworks Holdings IncTrade
Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par valueTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value trades at $66.26 (market cap $7.43B). The key difference: Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value is far larger — about 9.7× Ginkgo Bioworks Holdings Inc's market cap, and Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value is more actively traded (875,552 versus 3,204,177). Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value for 1 Days on average.

DNAVIST
Market Cap
$763.64M$7.43B
Volume
3,204,177875,552
Sector
HealthEnergy
52-Week High
$15.83$79.25
52-Week Low
$5.48$35.02
Typical Hold Time
7 Days1 Days
Enterprise Value
$865.59M$10.58B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.

DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.

Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DNA
47% Buy53% Sell
Avg holding period · 7 Days
VIST

No sentiment data available yet.

Top news

Latest headlines on both assets

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →

About Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value

Vista Energy is an independent oil and gas company focused on exploration, development, and production in Latin America. Its operations are centered on the Vaca Muerta formation in Argentina.

Read more on VIST →